Abstract

Originally introduced in 1988 as part of a duodenal switch operation [1,2], the laparoscopic sleeve gastrectomy (LSG) has become a popular primary procedure for morbidly obese patients. Although LSG is most often indicated for the super obese patient group, its use has recently been advocated for multiple subsets of the morbidly obese population, including patients with a body mass index >35 kg/m2 with co-morbidities, patients with contraindications for gastric adjustable banding, morbidly obese adolescents, and those patients for whom malabsorptive procedures would be contraindicated [3,4].

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call